SIG | Tumor-Related Epilepsy: A Focus on Low Grade Gliomas
Monday, December 6, 2021
-
You may need to log in to view video on this page.
OVERVIEW:
This Special Interest Group provides an update in the diagnosis and management of tumor-related epilepsy for low grade gliomas.
The session begins with a case of epilepsy associated with a low grade glioma, highlighting the role of imaging, challenges with antiseizure medication treatment, and some of the unanswered research questions in this population. Speakers also focus on the role of diagnostic imaging in low grade gliomas, followed by a discussion on evidence-based management for treatment in addition to how to identify and address side effects from antiseizure medications. The SIG concludes with a presentation of upcoming drug trials in low grade gliomas.
Learning Objectives:
Following participation in this activity, participants will be able to:
- Describe the approach to diagnostic imaging in low grade gliomas
- Identify the antiseizure medications which are most effective in this population based on scientific literature
- Describe ongoing drug trials in low grade gliomas
Program:
SIG Coordinators: Jessica Templer, MD, Thomas Wychowski, MD, and Edward Avila, DO
Chair: Jessica Templer, MD
Single Case of Low Grade Glioma | Jessica Templer, MD
Diagnostic Imaging in Low grade Gliomas | Jong Woo-Lee, MD, PhD
Evidence-Based Management of Treatement for Tumor-Related Epilepsy in Low Grade Gliomas | Marta Maschio, MD
Identifying and Addressing Adverse Effects of Antiseizure Medications in Tumor-Related Epilepsy | Thomas Wychowski, MD
Upcoming Drug Trials in Low Grade Gliomas | Padmaja Kandula, MD, FAES
Education Credit:
1.5 Nursing Contact Hours
1.5 Pharmacy Contact Hours
1.5 CME